Efficacy and safety of meningococcal vaccine group B OMV in healthy subjects.

Trial Profile

Efficacy and safety of meningococcal vaccine group B OMV in healthy subjects.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Meningococcal vaccine group B OMV Novartis (Primary) ; Meningococcal vaccine group B OMV
  • Indications Meningococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Nov 2010 New trial record.
    • 26 Jan 2005 Results of pooled analysis of four trials published in the Vaccine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top